Navigation Links
UN Reception Highlights Multi-Sector Partnerships in Global Public Health
Date:2/23/2009

Public and private health stakeholders working together to improve health in the developing world

NEW YORK, Feb. 23 /PRNewswire-USNewswire/ -- Promoting health among the world's poorest populations brought leaders from various nations, the global health community, biopharmaceutical companies, the media and international non-governmental organizations (NGOs) together today, highlighting the power of partnerships in advancing the global public health agenda.

The United Nations Economic and Social Council (ECOSOC) President H.E. Sylvie Lucas hosted, and CARE and the Global Health Progress initiative co-sponsored, an evening reception following today's special event on "Philanthropy and the Global Public Health Agenda." Key representatives from the public and private sector gathered to discuss the critical role multi-sector partnerships play in combating global disease and poverty -- from promoting maternal and child health, to fighting HIV and AIDS. The meeting and reception were designed to foster discussions on strengthening existing partnerships and creating new strategies to progress towards achieving the Millennium Development Goals, or MDGs.

"We are all in this together," said Chris Singer, President of the International Section at the Pharmaceutical Research and Manufacturers of America (PhRMA). "Promoting and strengthening partnerships to improve global health is something research-based biopharmaceutical companies remain strongly committed to."

Special issue and discussion tables were also featured at the reception, giving attendees the opportunity to learn more about global public health topics. The issues addressed included access to medicines, electronic and mobile health, the importance of ending fistula, HIV/AIDS, malaria and tuberculosis, the Millennium Villages and Millennium Promise, maternal, newborn and child health, neglected tropical disease, nutrition, public health capacity building, and vaccines.

"Innovative partnerships are crucial to CARE's work improving health in the world's poorest communities," said Cathy Woolard, CARE's Executive Vice President of Global Advocacy and External Relations. "We need to increase collaboration and collective action across the global health community. Urgent and complex issues such as safe motherhood, a topic CARE is particularly committed to, require strong collaborations within a global coalition of public, private and NGO entities to integrate and scale up successful models."

The Global Health Progress initiative brings research-based biopharmaceutical companies and global health leaders together to improve health in the developing world. CARE is a leading humanitarian organization fighting global poverty. Building on its 50-year history in maternal and child health, CARE's Mothers Matter initiative aims through partnerships to make pregnancy and delivery safe for 30 million women in 10 countries by 2015.

To learn more, visit www.care.org and www.globalhealthprogress.org.


'/>"/>
SOURCE Global Health Progress
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Susan G. Komen for the Cure Launches Komen Community Challenge With Governors Pink Ribbon Week Proclamation and Executive Mansion Reception
2. NuVasive Cancels 10/24/07 Investor Reception Due to Concerns Over Southern California Fires
3. Hologic, Inc. to Host Investor Reception at the RSNA Trade Show
4. Pay-For-Performance Not Getting a Red-Carpet Reception in Arizona
5. Stanford study highlights cost-effective method of lowering heart disease risks
6. REACH Registry Highlights That Patients With Peripheral Arterial Disease (PAD) Suffer High Rates of Heart Attack, Stroke, Hospitalization, and Death
7. Other highlights in the September 11 JNCI
8. NEWSWEEK International Editions: Highlights and Exclusives, Oct. 1, 2007 Issue
9. Georgia Pecans Fit!: New Campaign Highlights Health Benefits, Recipes, Web Site
10. Highlights from the October 2007 Journal of the American Dietetic Association
11. Stereotaxis Highlights New Data on Acute Success in AFib Treatments With Niobe Magnetic Navigation System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... Washington, DC (PRWEB) , ... May 26, 2016 , ... ... the National Hot Dog and Sausage Council (NHDSC) suggests that Americans prefer their dogs ... hot dogs, 63 percent say grilling is their favorite way to cook a hot ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... and clinical outcomes, hosted members and suppliers for its inaugural Member Conference at ... on their mission of elevating the operational health of America’s healthcare providers. , ...
(Date:5/26/2016)... , ... May 26, 2016 , ... On Memorial Day, ... women who lost their lives in military battle for the country. The nonprofit ... 2015 to provide more programs that empower independence for disabled military veterans, as well ...
(Date:5/26/2016)... ... May 26, 2016 , ... There are nearly 14.5 ... 32 million cancer survivors worldwide. On Sunday, June 5, 2016, communities around the world ... Cancer Survivors Day®. , National Cancer Survivors Day® is an annual worldwide Celebration ...
(Date:5/26/2016)... Farmingdale, NY (PRWEB) , ... May 26, 2016 ... ... and Hereditary Retinal Degeneration” for the Foundation Fighting Blindness, Long Island Chapter on ... free to the public. , Dr. Maisel, founder of Retina Group of ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... , May 24, 2016 ... médica para ayudar a los médicos a compartir sus ... pacientes a escala mundial. Profesionales médicos de Europa, África, ... se han apuntado a la aplicación, que combina la ... un entorno totalmente seguro. Educación   ...
(Date:5/24/2016)... , May 24, 2016  Diana Russell suffers ... her organs from the inside out.  This disease has ... dependent on her children and grandchildren to leave her ... wheelchair, Diana,s family cannot haul the wheelchair.  So if ... the car, and Diana is left to wait for ...
(Date:5/24/2016)... , May 24, 2016 Celsion ... drug development company, today provided an update on ... escalating clinical trial combining GEN-1, the Company,s DNA-based ... treatment of newly-diagnosed patients with advanced ovarian cancer ... debulking surgery.  GEN-1 is an IL-12 DNA plasmid ...
Breaking Medicine Technology: